DevCurationThe Premier Voice of the Entire Tech Ecosystem
Home
Where the Money Moved
News
Events
Investor Spotlight
Company Spotlight
Frameworks
DevCuration
Home
Where the Money Moved
News
Events
Investor Spotlight
Company Spotlight
Frameworks
DevCuration
Latest
Maxinsights Raises $30M Seed for Physical AI Training Data|Warp Sciences Raises $215M Series A for US Chemistry Labs|Formic Raises $50M for Factory Robotics and Physical AI|BioStack Raises $9.5M Seed for Medical AI Training Data|WILDE Gets $40M from S2G to Expand Protein Snack Range|Bison Ventures Closes $160M Fund 2 for Frontier Startups|Rivian Acquires Third Dimension AI for Driving Simulation|Enact Intelligence Raises $30M for Force-Aware Robotics|Kevel Raises $52M to Scale Independent Commerce Media|Legora Raises $550M Series E at $8.8B Valuation|Maxinsights Raises $30M Seed for Physical AI Training Data|Warp Sciences Raises $215M Series A for US Chemistry Labs|Formic Raises $50M for Factory Robotics and Physical AI|BioStack Raises $9.5M Seed for Medical AI Training Data|WILDE Gets $40M from S2G to Expand Protein Snack Range|Bison Ventures Closes $160M Fund 2 for Frontier Startups|Rivian Acquires Third Dimension AI for Driving Simulation|Enact Intelligence Raises $30M for Force-Aware Robotics|Kevel Raises $52M to Scale Independent Commerce Media|Legora Raises $550M Series E at $8.8B Valuation
DevCuration

The premier voice of the tech ecosystem, from ideation to enterprise.

Explore

  • Where the Money Moved
  • Events
  • Articles & Analysis

Spotlights

  • Investor Spotlight
  • Company Spotlight
  • Frameworks

Company

  • About Us
  • Privacy Policy
  • Terms of Service
© 2026 DevCuration. All rights reserved.
TwitterLinkedIn
Logos provided by Logo.dev
Back to Ecosystem Intelligence
Beren Therapeutics

Beren Therapeutics

A clinical-stage biotechnology company focused on cyclodextrin-based therapies for diseases involving impaired cholesterol trafficking.

UnknownEarly Stage
Total Funding
—
Employees
—
Headquarters
Thousand Oaks, California
Founded
—

About

Categories

Funding History

Round
Amount
Date
Lead Investors
combined equity and non-dilutive financing
$300M
June 12, 2026
Hercules Capital